Jessica Hagen
GV, Thrive Capital and Salesforce Ventures led the company's seed funding round.
During a discussion at ViVE 2023, panelists emphasized the need to interrogate data and know how it could be biased.
The company will use the funds to continue its growth in the U.S.
The company has let go of approximately 35% of its workforce.
The company is adding three nutrition tools to its platform that allow providers to supply food recommendations, recipes and tailored grocery lists to their patients.
The company's product, Prism, uses neurofeedback to help PTSD patients learn to control their emotional response.
The AI-powered app allows for remote monitoring of common Parkinson's disease symptoms such as bradykinesia, tremor and dyskinesia via an Apple Watch.
The company will use the funds to advance the study of its neuromodulation device intended to treat Alzheimer's disease.
A study published in The New England Journal of Medicine found a closed-loop control system kept children's glucose levels in the target range longer than standard care.
Blood-collection device-maker Vitestro, tech-enabled baby bottle designer Emulait, digital health support platform Reveal HealthTech and AI-based testing platform PocDoc also received funding.